NCT04955613

Brief Summary

The treatment system consists of two light-weight MyMove bands and virtual-reality gear. Built-in software allows tracking of performance in real-time, with feedback to both the patient and treating personnel. MyMove is a wearable device that allows patients with loss of upper-limb function to operate computers, cellular phones, and similar devices. The technology is non-invasive and does not involve risk to the patient. MyMove+ is a Physical Medicine and Rehabilitation software intended for use in upper extremity and full-body conventional rehabilitation by:

  1. 1.Tracking motion and movement kinematics.
  2. 2.Guiding patients in the performance of physical exercises according to the treating practitioner's guidelines.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
122

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 5, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 9, 2021

Completed
20 days until next milestone

Study Start

First participant enrolled

July 29, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2022

Completed
Last Updated

July 9, 2021

Status Verified

May 1, 2021

Enrollment Period

8 months

First QC Date

May 5, 2021

Last Update Submit

June 29, 2021

Conditions

Keywords

phantom limb painVASTelerehabilitation

Outcome Measures

Primary Outcomes (1)

  • Pain change

    Demonstrate non-inferiority in comparison with existing treatments - change pain level by at least two visual analog scale (VAS) levels. VAS scale runs from 0 (pain-free) to 10 (extreme pain).

    12 months

Secondary Outcomes (1)

  • Physical Rehabilitation Recovery

    12 months

Study Arms (2)

Standard care

ACTIVE COMPARATOR

12 sessions in total: sessions 1: Meeting with a doctor and physical therapist. sessions 2-11:Mirror therapy (standard care) for a total of 10 sessions over a period of 5 weeks (15-20 minutes per session). sessions 12: Meeting with a doctor and physical therapist.

Device: Mirror therapy

MyMove/VR system

ACTIVE COMPARATOR

sessions 1: Meeting with a doctor and physical therapist. sessions 2-11:MyMove devices and VR gear for a total of 10 sessions over a period of 5 weeks 15-20 minutes per session. sessions 12: Meeting with a doctor and physical therapist.

Device: MyMove/VR system

Interventions

The treatment system consists of two lightweight MyMove bands and Virtual-Reality (VR) gear. Proprietary software and content allow tracking of performance in real-time, with feedback to both the patient and treating - personnel. MyMove is a wearable device that allows patients with loss of upper limb function to operate computers, cellular phones, and similar devices. The technology is non-invasive and does not involve risk to the patient. Virtual-Reality (VR) gear is a wearable computer running within goggles that project content and allow for interaction using controllers.

MyMove/VR system

Mirror therapy or mirror visual feedback is a therapy for pain or disability that affects one side of the patient more than the other side

Standard care

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clearance by the treating physician.
  • Unilateral below-knee amputation
  • History of phantom-limb pain with an intensity of 5-or-greater (VAS scale)
  • Pain is not responsive to conventional drugs or other standard treatment.
  • Range of motion (knee) of 10-to-90 degrees.

You may not qualify if:

  • Bilateral amputation
  • History of phantom-limb pain with an intensity of 4-or-less (VAS scale)
  • No prior attempt at therapy
  • Declined by patient
  • Pregnancy or other limitation related to special health-care groups.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sheba Medical Center'

Ramat Gan, 52621, Israel

RECRUITING

Related Publications (6)

  • Hoffman HG, Boe DA, Rombokas E, Khadra C, LeMay S, Meyer WJ, Patterson S, Ballesteros A, Pitt SW. Virtual reality hand therapy: A new tool for nonopioid analgesia for acute procedural pain, hand rehabilitation, and VR embodiment therapy for phantom limb pain. J Hand Ther. 2020 Apr-Jun;33(2):254-262. doi: 10.1016/j.jht.2020.04.001. Epub 2020 May 30.

    PMID: 32482376BACKGROUND
  • Ziegler-Graham K, MacKenzie EJ, Ephraim PL, Travison TG, Brookmeyer R. Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil. 2008 Mar;89(3):422-9. doi: 10.1016/j.apmr.2007.11.005.

    PMID: 18295618BACKGROUND
  • Sherman RA, Sherman CJ, Parker L. Chronic phantom and stump pain among American veterans: results of a survey. Pain. 1984 Jan;18(1):83-95. doi: 10.1016/0304-3959(84)90128-3.

    PMID: 6709380BACKGROUND
  • McCormick Z, Chang-Chien G, Marshall B, Huang M, Harden RN. Phantom limb pain: a systematic neuroanatomical-based review of pharmacologic treatment. Pain Med. 2014 Feb;15(2):292-305. doi: 10.1111/pme.12283. Epub 2013 Nov 13.

    PMID: 24224475BACKGROUND
  • Ramachandran VS, Rogers-Ramachandran D. Synaesthesia in phantom limbs induced with mirrors. Proc Biol Sci. 1996 Apr 22;263(1369):377-86. doi: 10.1098/rspb.1996.0058.

    PMID: 8637922BACKGROUND
  • Weeks SR, Anderson-Barnes VC, Tsao JW. Phantom limb pain: theories and therapies. Neurologist. 2010 Sep;16(5):277-86. doi: 10.1097/NRL.0b013e3181edf128.

    PMID: 20827116BACKGROUND

MeSH Terms

Conditions

Phantom Limb

Interventions

Mirror Movement Therapy

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPain, PostoperativePostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsPain

Intervention Hierarchy (Ancestors)

Physical Therapy ModalitiesRehabilitationTherapeutics

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: A non-blinded controlled study of adults. Each patient admitted to the study will be randomly allocated to either the treatment or control group (provided standard care) in consecutive order.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 5, 2021

First Posted

July 9, 2021

Study Start

July 29, 2021

Primary Completion

April 1, 2022

Study Completion

August 1, 2022

Last Updated

July 9, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

Data is system-specific to the MyMove bands and can only be analyzed with embedded algorithm reference.

Locations